Acadia Pharmaceuticals to Announce Third Quarter 2025 Financial Results on November 5, 2025 Biotech Investing
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma Biotech Investing
Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025 Biotech Investing
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal Biotech Investing
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption Biotech Investing
PharmaTher Announces KetAImine - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505 NDA Filings Biotech Investing
Summit Therapeutics to Host ESMO Data Update & Third Quarter Earnings Call on October 20, 2025 Biotech Investing
Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference Biotech Investing
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
